ArticleCell reports. Medicine2026

Transgenic mouse-derived human monoclonal antibodies targeting EBV gp350 and gp42 provide basis for therapeutic development.

Crystal B Chhan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.